TransThera Sciences (Nanjing). Inc.
Status: Publicly traded
Direct answer
TransThera Sciences (Nanjing). Inc. is publicly traded on HKSE under the ticker 2617.HK.
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases. The company provides Tinengotinib (TT-00420), a MTK inhibitor that is in clinical stage for the treatment of recurrent or refractory drug-resistant solid tumors. It also develops TT-00973, a kinase inhibitor for...
Can you invest in TransThera Sciences (Nanjing). Inc.?
Yes. TransThera Sciences (Nanjing). Inc. is publicly traded on HKSE under the ticker 2617.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for TransThera Sciences (Nanjing). Inc.
Detailed equity research is provided by MarketSnap.